Labcorp grows business outside of Covid-19 by 10% in first quarter with spin-off still on track for mid-2023

Labcorp appears to be refocusing its efforts away from Covid-19 as the world emerges from the pandemic, with its Q1 FY2023 financial results negatively impacted by the decrease in Covid-19 testing while it also grew its other business sectors.